NEW YORK (TheStreet) -- Goldman Sachs upgraded Envision Healthcare  (EVHC) to "buy" from "neutral," set a $43 price target and placed the stock on its Conviction List. The firm noted the company's outlook is improving and it trades at a compelling valuation.

The stock closed at $35.95 on Friday.

Must Read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

EVHC Chart

EVHC data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Bank of America, Goldman Sachs, Brexit, Snap and Sears - 5 Things You Must Know

Bank of America, Goldman Sachs, Brexit, Snap and Sears - 5 Things You Must Know

Eddie Lampert Pays $5.2 Billion to Save Sears from Liquidation - Reports

Eddie Lampert Pays $5.2 Billion to Save Sears from Liquidation - Reports

Microsoft Shares Up After Major Health Care Deal With Walgreens

Microsoft Shares Up After Major Health Care Deal With Walgreens

Device Maker Microbot Medical Gives Back Gains

Device Maker Microbot Medical Gives Back Gains

Arconic Shares Rise as Deal Nears for Aerospace Firm

Arconic Shares Rise as Deal Nears for Aerospace Firm